10x Genomics Analyst Ratings
10x Genomics Analyst Ratings
10x Genomics Stock Slides 14% Amid Illumina Deal, Deutsche Downgrade
Goldman Sachs Adjusts Price Target on 10x Genomics to $16 From $26, Maintains Sell Rating
10x Genomics Analyst Ratings
10x Genomics Analyst Ratings
10x Genomics Analyst Ratings
10x Genomics Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)
UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating
10x Genomics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Axonics Modulation Technologies (AXNX) and Eli Lilly & Co (LLY)
Analysts' Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)
10x Genomics Analyst Ratings
10x Genomics Analyst Ratings
10x Genomics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)
UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Travere Therapeutics (TVTX) and 10x Genomics (TXG)
10x Genomics Analyst Ratings